<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=791796650947760&amp;ev=PageView&amp;noscript=1">

Store-A-Tooth™ Dental Stem Cell Banking and Product News

Stem cells restore function after a stroke

Posted by James Andrews on Thu, Apr 05, 2012 @ 10:08 AM

Treating Strokes with stem cellsWhat's happening:

A unique trial is being conducted to test the use adult stem cells from a stroke patient's own stem cells to restore their mobility and function.

Stroke Stats:

#3 cause of death in the United State
#1 cause of disability in the United States.

For many victims of stroke, surviving it is just the beginning - with many left fighting to regain complete motor function for the rest of their lives.

Meet Valisa

Valisa lost some motor function in the right side of her body. Two million brain cells die every minute during a stroke. Doctors use clot-busting drugs to help prevent that from happening, after that, there's only a 15 to 20 percent chance of improvement according to them.

Now a first-of-its-kind trial is testing the use of a stroke patient's own stem cells to restore function.

"They are a population of cells you retain in your body that have the ability to turn into other things," explained the doctor.

Doctors think the stem cells might act as instructive cells, telling the brain how to heal.  

According to the doctor, "we take the stem cells that your body normally uses to make red blood cells and separate those stem cells out of the bone marrow."  Doctors then inject them into the affected side of the brain through the groin.

The doctor says the science behind this is incredible.

In mice, there was a 40-percent improvement in motor skills.  "I think that's one of the most potentially exciting things in my field ever," said Dr. Rappard.

Valisa is part of the double blind human study.  While she doesn't know if she received the stem cells or not, it's given her hope toward a full recovery. 

The phase one trial involved 10 patients. Doctors hope to enroll at least 100 for phase two. Only patients with ischemic strokes will be eligible to participate in the clinical trial.

Tags: Research, Healthcare, Regenerative Medicine

Subscribe to Email

Latest Posts

Follow Me